What is the next earnings date for CSCI stock?
COSCIENS BIOPHARMA INC (CSCI.CA) will report earnings on 2026-04-07, after the market close.
COSCIENS BIOPHARMA INC (CSCI.CA) Forecast, Price Target & Analyst Ratings
TSX:CSCI • CA22112H1010
Current stock price
1.78 CAD
-0.18 (-9.18%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COSCIENS BIOPHARMA INC (CSCI.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$1.78 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
CSCI.CA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CSCI.CA.
In the previous month the buy percentage consensus was at a similar level.
CSCI.CA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 7, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 5.6M 5.66% | 7.143M 27.55% | 9.587M 34.22% | |
| EBITDA YoY % growth | -15.06M -76.14% | -3.186M 78.84% | -12.416M -289.70% | |
| EBIT YoY % growth | -15.2M -74.71% | -4.629M 69.55% | -14.023M -202.94% | |
| Operating Margin | -271.43% | -64.80% | -146.27% | |
| EPS YoY % growth | -11.76 -92.16% | -13.64 -15.99% | N/A 74.80% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A